Suppliers / Jiangxi Nuclear Industry Reyphon Bio-Chemical

Jiangxi Nuclear Industry Reyphon Bio-Chemical

China Updated 9 July 2026

Jiangxi Nuclear Industry Reyphon Bio-Chemical is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Polymyxin B US FDA 1

Also appears on these molecule pages

Questions about Jiangxi Nuclear Industry Reyphon Bio-Chemical

Does Jiangxi Nuclear Industry Reyphon Bio-Chemical hold a US DMF or a CEP?
Jiangxi Nuclear Industry Reyphon Bio-Chemical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangxi Nuclear Industry Reyphon Bio-Chemical make?
1 molecule is on record against Jiangxi Nuclear Industry Reyphon Bio-Chemical, including Polymyxin B. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Check Jiangxi Nuclear Industry Reyphon Bio-Chemical's supplier records

Review its manufacturing sites and inspection history in PharmaDB.

Sign up free
Free with a work email. No password.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability